Background: Numerous studies from different labs around the world report human cardiac progenitor cells (hCPCs) as having a role in myocardial repair upon ischemia/reperfusion (I/R) injury, mainly through auto/paracrine signaling. Even though these cell populations are already being investigated in cell transplantation-based clinical trials, the mechanisms underlying their response are still poorly understood.Methods: To further investigate hCPC regenerative process, we established the first in vitro human heterotypic model of myocardial I/R injury using hCPCs and human-induced pluripotent cell-derived cardiomyocytes (hiPSC-CMs). The co-culture model was established using transwell inserts and evaluated in both ischemia and reperfusion phas...
Rationale: Multiple biological mechanisms contribute to the efficacy of cardiac cell therapy. Most p...
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has int...
Cardiac Progenitor Cells (CPCs) show great potential as a cell resource for restoring cardiac functi...
Abstract Background Numerous studies from different labs around the world report human cardiac proge...
Background: Numerous studies from different labs around the world report human cardiac progenitor ce...
After an Acute Myocardial Infarction (AMI), Ischemia-Reperfusion (I/R) injury is responsible for a c...
Acute Myocardial Infarction (AMI) remains a leading cause of death worldwide. After AMI, clinical re...
Cardiovascular disorders are currently the leading cause of death in the Western world. Myocardial i...
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has int...
Aims: Cardiovascular diseases caused by loss of functional cardiomyocytes (CMs) are a major cause of...
Aims: Cardiovascular diseases caused by loss of functional cardiomyocytes (CMs) are a major cause of...
Aims: Cardiovascular diseases caused by loss of functional cardiomyocytes (CMs) are a major cause of...
Myocardial infarction and heart failure are major causes of death worldwide. The adult heart has lim...
Cardiovascular disease (CVD) is the leading causes of morbidity and death globally. In particular, a...
Following ischemic injury, the myocardium undergoes extensive cardiomyocyte loss, scar formation and...
Rationale: Multiple biological mechanisms contribute to the efficacy of cardiac cell therapy. Most p...
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has int...
Cardiac Progenitor Cells (CPCs) show great potential as a cell resource for restoring cardiac functi...
Abstract Background Numerous studies from different labs around the world report human cardiac proge...
Background: Numerous studies from different labs around the world report human cardiac progenitor ce...
After an Acute Myocardial Infarction (AMI), Ischemia-Reperfusion (I/R) injury is responsible for a c...
Acute Myocardial Infarction (AMI) remains a leading cause of death worldwide. After AMI, clinical re...
Cardiovascular disorders are currently the leading cause of death in the Western world. Myocardial i...
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has int...
Aims: Cardiovascular diseases caused by loss of functional cardiomyocytes (CMs) are a major cause of...
Aims: Cardiovascular diseases caused by loss of functional cardiomyocytes (CMs) are a major cause of...
Aims: Cardiovascular diseases caused by loss of functional cardiomyocytes (CMs) are a major cause of...
Myocardial infarction and heart failure are major causes of death worldwide. The adult heart has lim...
Cardiovascular disease (CVD) is the leading causes of morbidity and death globally. In particular, a...
Following ischemic injury, the myocardium undergoes extensive cardiomyocyte loss, scar formation and...
Rationale: Multiple biological mechanisms contribute to the efficacy of cardiac cell therapy. Most p...
The loss of endogenous cardiac regenerative capacity within the first week of postnatal life has int...
Cardiac Progenitor Cells (CPCs) show great potential as a cell resource for restoring cardiac functi...